Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,229 | 4,055 | 5,122 | 3,281 | 5,028 |
| TOTAL | $8,592 | $4,697 | $5,576 | $3,930 | $5,615 |
| Non-Current Assets | |||||
| PPE Net | 3 | 1 | 2 | 3 | 4 |
| Other Non-Current Assets | 71 | 84 | 97 | 109 | 120 |
| TOTAL | $74 | $85 | $99 | $112 | $124 |
| Total Assets | $8,666 | $4,782 | $5,675 | $4,042 | $5,739 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,837 | 1,317 | 1,297 | 1,361 | 897 |
| Accrued Expenses | 750 | 1,388 | 960 | 1,368 | 691 |
| TOTAL | $2,643 | $2,759 | $2,309 | $2,779 | $1,636 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 15 | 30 | 44 | 58 | 71 |
| TOTAL | $15 | $30 | $44 | $58 | $71 |
| Total Liabilities | $2,658 | $2,789 | $2,353 | $2,837 | $1,707 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,445 | 117 | 90 | 76 | 19 |
| Retained earnings | -51,696 | -49,037 | -45,678 | -42,786 | -39,740 |
| TOTAL | $6,008 | $1,993 | $3,322 | $1,205 | $4,032 |
| Total Liabilities And Equity | $8,666 | $4,782 | $5,675 | $4,042 | $5,739 |